Skip to main content

Peer Review reports

From: A 12-month, prospective, observational study of ranibizumab in treatment-naïve Taiwanese patients with neovascular age-related macular degeneration: the RACER study

Original Submission
1 Aug 2020 Submitted Original manuscript
1 Sep 2020 Reviewed Reviewer Report
6 Sep 2020 Reviewed Reviewer Report
25 Sep 2020 Author responded Author comments - Wen-Chuan Wu
Resubmission - Version 2
25 Sep 2020 Submitted Manuscript version 2
12 Oct 2020 Reviewed Reviewer Report
26 Oct 2020 Author responded Author comments - Wen-Chuan Wu
Resubmission - Version 3
26 Oct 2020 Submitted Manuscript version 3
1 Nov 2020 Author responded Author comments - Wen-Chuan Wu
Resubmission - Version 4
1 Nov 2020 Submitted Manuscript version 4
Publishing
2 Nov 2020 Editorially accepted
25 Nov 2020 Article published 10.1186/s12886-020-01715-3

You can find further information about peer review here.

Back to article page